CSAR Benchmark Exercise of 2010: Combined Evaluation Across All Submitted Scoring Functions by Smith, Richard D. et al.
Published: August 03, 2011
r2011 American Chemical Society 2115 dx.doi.org/10.1021/ci200269q|J. Chem. Inf. Model. 2011, 51, 2115–2131
ARTICLE
pubs.acs.org/jcim
CSAR Benchmark Exercise of 2010: Combined Evaluation Across All
Submitted Scoring Functions
Richard D. Smith,
† James B. Dunbar, Jr.,
† Peter Man-Un Ung,
† Emilio X. Esposito,
† Chao-Yie Yang,
‡
Shaomeng Wang,
‡ and Heather A. Carlson*
,†
†Department of Medicinal Chemistry, University of Michigan, 428 Church Street, Ann Arbor, Michigan 48109-1065, United States
‡Department of Internal MedicineHematology/Oncology, University of Michigan, 1500 East Medical Center Drive, 7216 CC,
Ann Arbor, Michigan 48109-0934, United States
b S Supporting Information
’INTRODUCTION
Over the past two decades, docking has advanced from an
academicexercisetoausefultooltohelpdevelopnewleadsinthe
pharmaceutical industry. Structure-based drug discovery
(SBDD) methods are very successful in enriching hit rates, but
it is possible that current software programs are really more
eﬀective at eliminating bad leads than identifying good ones.
1
While the ultimate goal is to properly predict tight binders,
removing poor choices is valuable and focuses experiments into
more fruitful chemical space.
A study by Warren et al.
2 summarizes many of the current
strengths and limitations of SBDD. Many docking and scoring
routines didwellatbinding mode prediction, reproducingligand
poses within 2 Å. Some were successful at virtual screening and
yieldedenrichmentsappropriatefor lead identiﬁcation, but none
could rank order ligands by aﬃnity. In general, inhibitors with
nM-level aﬃnity cannot be consistently ranked over those with
μM-level binding. It is not possible to identify “activity cliﬀs,”
small changes that result in signiﬁcant increases or decreases in
aﬃnity.
Overall,thereisaclearconsensusthatdockingandscoringisa
useful technique with potential to be even better, and the need
for better training data is commonly identiﬁed as a limitation
facing the ﬁeld.
1 The aim of the Community Structure-Activity
Resource (CSAR) is to gather data to help scientists improve
their methods. To learn what features are most important to
address ﬁrst, we devised our 2010 benchmark exercise. Our
exerciseisintendedtobringpeopletogethertocomparediﬀerent
methods and improvements for scoring functions based on
crystal structures of proteinligand complexes (no docking
was required in order to remove any limitations or biases arising
from the use of diﬀerent search algorithms). Our data set
contains hundreds of diverse proteins and ligands of the highest
quality that can be used to identify which systems are inﬂuenced
by diﬀerent approaches. For a detailed description of how the
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ABSTRACT: As part of the Community Structure-Activity
Resource (CSAR) center, a set of 343 high-quality, protein
ligand crystal structures were assembled with experimentally
determined Kd or Ki information from the literature. We
encouraged the community to score the crystallographic poses
of thecomplexes byanymethod of theirchoice.The goalofthe
exercise was to (1) evaluate the current ability of the ﬁeld to
predictactivityfromstructureand(2)investigatetheproperties
of the complexes and methods that appear to hinder scoring. A
total of 19 diﬀerent methods were submitted with numerous
parametervariationsforatotalof64setsofscoresfrom16participatinggroups.Linearregressionandnonparametrictestswereused
tocorrelatescorestotheexperimentalvalues.CorrelationtoexperimentforthevariousmethodsrangedR
2=0.580.12,Spearman
F=0.740.37,Kendallτ=0.550.25,andmedianunsignederror=1.001.68pKdunits.Alltypesofscoringfunctions—forceﬁeld
based,knowledge based, andempirical—had exampleswithhighandlow correlation, showing no bias/advantage foranyparticular
approach.Thedataacrossalltheparticipantswerecombinedtoidentify63complexesthatwerepoorlyscoredacrossthemajorityof
the scoring methods and 123 complexes that were scored well across the majority. The two sets were compared using a Wilcoxon
rank-sum test to assess any signiﬁcant diﬀerence in the distributions of >400 physicochemical properties of the ligands and the
proteins. Poorly scored complexes were found to have ligands that were the same size as those in well-scored complexes, but
hydrogenbondingandtorsionalstrainweresigniﬁcantlydiﬀerent.ThesecomparisonspointtoaneedforCSARtodevelopdatasets
of congeneric series with a range of hydrogen-bonding and hydrophobic characteristics and a range of rotatable bonds.2116 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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data set was curated and prepared for the exercise, the reader is
directed to our data set paper in this same issue.
3 Most evalua-
tions in the literature are based on a handful of targets at most,
and that limited scope prevents us from properly identifying
which features of targets and ligands are most diﬃcult to treat
computationally. Furthermore, it does not point toward how to
improve our methods.
Here, we present an evaluation across all participants, parti-
cularly noting which proteinligand systems are the most
diﬃcult to score and which are scored well. Our hypothesis is
thatsoundstatisticalmethodscanbeusedtoidentifyweaknesses
incurrentscoringfunctions.Targetsthatarepoorlyscoredacross
many, diverse methods point to common deﬁciencies in SBDD.
These are the systems that call for improved approaches,
departures from the status quo. For CSAR, the diﬀerences in
physicochemical properties of the “universally well scored”
complexes (GOODs) vs “universally poorly scored” (BADs)
help to direct the kinds of data sets we curate. Inthis analysis, we
are particularly interested in the complexes that are consistently
scored well versus those that consistently scored poorly. GOOD
complexes score within 1.1 pKd of the experimental binding
aﬃnityforatleast12ofthe17scoringfunctionsdescribedbelow,
andBADmustbeoutliersfor12ormoreofthescoringfunctions,
see Figure 1. The BAD complexes fall into two groups: OVERs
are weak binders that are consistently overscored, and UNDERs
are tight binders that are consistently underscored. Diﬀerences
in the physicochemical properties of GOODs versus BADs help
to identify strengths and weaknesses of current approaches.
Below, we show that OVERs tend to have hydrophilic ligands
and binding sites, while UNDERs are typically hydrophobic.
This highlights the need for eﬀorts like CSAR to develop data
setsbasedoncongenericserieswithranginglogPandhydrogen-
bondingfeatures.Thisisfurthersupportedbytheresultsofthree
participants in the exercise who found that removing hydrogen-
bondingtermsand/orCoulombicenergiesresultedinnochange
in the agreement between scores and experimental aﬃnities. In
fact, the correlations signiﬁcantly improved for one participant
(see the papers of this special issue).
Themostimportantaspectofthisanalysisisthemeansweuse
to combine the scoring functions. Improvement is regularly
found by combining scores, and it is typically independent of
whichscoringfunctionsarecombined.
4Researchinvolvingbelief
theory
57 and consensus scoring
4,824 has focused on ways to
combine data to identify potential positive outcomes, such as
enrichment of hit rates. Here, we use consensus to determine
which complexes are not scored well. It is very important to
design the methods for combining results so that the statistical
treatment makes it extremely unlikely for these choices to result
fromrandom chanceornoise inthedata. Theequallyimportant,
subsequenttaskfocusesondeterminingwhythesecomplexesare
outliers.
Statistics. The methods used are straightforward and well-
defined, based on linear regression. The most common assess-
ment for a scoring function is its correlation to experimental
bindingdata.Whenusingasimple,least-squareslinearregression
to fit data points, the fit line must intersect the point (x, y), and
the slope is defined to minimize the distance in the y direction
between the data points and the line.
25 An underlying assump-
tion is that the data has a normal distribution along the y axis.
Indeed, the distribution of the 343 affinities in the CSAR-NRC
set
3 is normally distributed about its average affinity (average
pKd/i = 6.15, median = 6.19, max = 13, min = 0.15) with the
skew and kurtosis near 0 (skew = 0.06, kurtosis = 0.04).
Therefore, the distribution of the residuals (errors in the y
direction off any fit line) is normally distributed and centered
at zero, see Figure 1. The standard deviation (σ) of the residuals
isdirectlyrelatedtothegoodnessoffitoftheline(smallerσasR
2
approaches1).R
2isthesquareofthePearsoncorrelationcoefficient
which is the percentage of the total variation that can be fit by the
linear relationship.
Ifwedeﬁneanoutlierasanypointwithanabsoluteerrorg1σ,
then the probability of that occurrence is well-deﬁned: 15.8%
for each tail in the distribution of the residuals. This is true
regardless of the R
2, so all ﬁts—tighter and weaker—have the
Figure 1. Example of comparing a set of scores, pKd (calculated), to
their corresponding experimentally determined aﬃnities. (Top) When
ﬁtting a line (black) using least-squares linear regression, the distance in
the y direction between each data point and the line is its residual.
(Bottom)Theresidualsforallthedatapointshaveanormaldistribution
around zero. The characteristics are well-deﬁned, including the deﬁni-
tion of standard deviation (σ in red, which happens to be 1.4 pKd in this
example) and the number of data points with residuals outside ( σ
(15.8% in each tail). Higher correlations lead to larger R
2 and smaller σ;
weaker correlations lead to lower R
2 and larger σ, but the distributions
remain Gaussian in shape.2117 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
Journal of Chemical Information and Modeling ARTICLE
same probability of a complex having its residual in the tail
regions. Below, we combine 17 scoring functions to identify
common outliers or BAD complexes that are poorly scored over
most methods. If a complex was poorly scored in all 17 scoring
functions,thentheprobabilityofitbeingarandom occurrenceis
2  (0.158)
17 = 4.77  10
14, where the factor of 2 accounts for
the fact that an outlier can be either consistently above 1σ or
consistently below 1σ to be a common outlier by our deﬁni-
tion. The probability of a complex being a common outlier for
16 of 17 scores is 2  (0.158)
16  (0.842)  17= 4.32  10
12,
where the factor of 17 accounts for the number of ways that one
scoring function can have an error <1σ. Following this enumera-
tion, we can show that the probability of a complex being
a common outlier for 12 or more of the 17 scoring functions
due entirely to random occurrence is 1.27  10
6. We would
need a data set of 787400 complexes (1/probability) to have
one common outlier from random chance. That is 3 orders of
magnitude larger than the CSAR-NRC data set, making it
basically impossible for any of the common outliers to be due
to random chance.
Our deﬁnition of g12 of 17 scores (at least 70% of the
methods) ensures that common outliers do not occur randomly.
Therefore, if a complex is a common outlier, there has to be an
underlying cause. It has to represent some type of molecular
recognition that most methods treat insuﬃciently. In order to
identify the physicochemical properties that may frustrate com-
putational methods, we compared the distribution of those
properties between the BAD complexes and the set of GOOD
complexes. The set of GOOD complexes was deﬁned as
those which scored within 1.1 pKd of their experimental value
(|residuals| e 1.5 kcal/mol) for g12 of 17 scoring functions.
Once these two sets were identiﬁed, two-tailed Wilcoxon rank-
sumtestswereusedtoassessstatisticalsigniﬁcanceofdiﬀerences
in their distributions of physicochemical properties. Of course,
we cannot completely rule out experimental error as a cause for
an outlier. Our preparation of the data set removed all common
complications, such as crystal contacts or poor electron density
for the ligand, but the inherent weaknesses of using crystal
structures are still there. We are not accounting for protein
ﬂexibility nor are we correcting for any diﬀerences in ions or pH
between the binding assay and the crystallization conditions.
There could be errors in the aﬃnity data, particularly for very
weak or very strong aﬃnity where measurements are pushed to
theirlimits.Foralloutliers,wesearchedtheliteratureforupdated
aﬃnity data, but none was found.
Contributors. Most of the scores were calculated by authors
featured in this special issue, some by the CSAR team, and a few
by participants who spoke at the ACS symposium
26 but were
unable to submit papers due to various time constraints. Parti-
cipants were promised anonymity to encourage submission of
scores, even those with poor agreement with experiment, but
attendees of the ACS symposium felt that hiding the identity of
the scoringfunctions made it impossible to assess the results and
know what inherent weaknesses might underlie the analysis. For
that reason, the scoring functions are listed in the Methods
Section below.
However, we stress that the list of scoring functions is ordered
alphabetically,and it isnot related to the ordering used intheResults
and Discussion Section. In the discussions below, each scoring
function is denoted with the generic term “code X”, where X =
117. We have chosen not to link the identity of the scoring
functions with their performance to avoid trivializing this work
into“winnersvslosers.”Thisbenchmarkexerciseisnotacontest,
and ranking current scoring functions was not our mission. Our
goalistocombinethedataacrossallparticipantsandidentifythe
most important and universal deﬁciencies in scoring pro-
teinligand binding. Only by knowing where the most signiﬁ-
cant pitfalls lie can we prioritize which data are needed most to
help the community develop their new methodologies. This
information has helped direct the focus of CSAR’s future
data sets.
’METHODS
The CSAR-NRC data set
3 is 343 proteinligand complexes
withbindingaﬃnitydata(KdorKiwhichweabbreviateaspKd/i)
from Binding MOAD
27,28 and PDBbind.
29,30 The challenge to
participants was to calculate absolute free energies of binding
over a very diverse set of proteins and small molecule ligands.
The set was originally divided into two subsets so that partici-
pants could examine training and testing on related sets if they
wished, but for this analysis, we are examining scoring across the
full set of data.
We wanted an equivalent comparison across all the methods.
To removebias/error from diﬀerent docking search routines, we
asked participants to simply score poses from the crystal struc-
tures of the complex. The electron densities for ligands in the
CSAR-NRC set are exceptional (RSCC g 0.9 for the ligands),
3
so usingposesfromthecrystalsshould beanunbiasedtreatment
for all methods. However, we found that force ﬁeld (FF)-based
methods required minimization of the complexes. Small over-
laps, within the error of the coordinates, were enough to create
very large van der Waals (vdW) penalties. Therefore, a set of
minimized structures were made available in addition to the set
of crystallographic complexes. All FF methods used the same
minimized structures for consistency. Though we could have
askedforeachFFmethodtousestructuresminimizedinthatFF,
itwouldhaveremovedtheemphasisofanevencomparison. The
minimizations were simply meant to remove the vdW overlaps
that undermined their performance. While this is not ideal, it
aims to create an even basis for comparison. Participants were
welcome to minimize the structures in their own FF, score again
as part of their analysis, and report the results in their papers.
They were also able to use crystallographic water if they chose,
but none were used in the core scores below.
Sixteen groups participated in the benchmark exercise: 11
academic and 5 from the private sector, both software vendors
and pharma groups. The submissions for the CSAR-NRC set
included64variationson19scoringfunctions.Mostparticipants
submitted more than one set of scores, varying diﬀerent para-
metric choices to determine their inﬂuence upon scoring. Two
of the methods were only trained on the CSAR-NRC set and
could not be included in this analysis. For each of the other 17
methods submitted, an optimal “core” score was chosen for our
combined analysis across all participants. Only standard ap-
proaches were considered (only pre-existing functional choices,
not functions ﬁt to the CSAR-NRC data set). The option most
appropriatetoavoidartifactswaschosen.Forexample,FFscores
require minimization of the complexes to remove the artifact
of high vdW energies. Minimization was usually unnecessary
for soft potentials or knowledge-based potentials, and use of
the minimized structures often showed decreased agreement
with experimental values. If more than one standard approach
was submitted, then the option with better root-mean-square2118 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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error (RMSE) or R
2 to the experimental data was chosen. At
times, this resulted in minimized structures being used with
knowledge-based or soft scoring functions. As noted above, the
order below is alphabetical, but the tables, ﬁgures, and various
performance metrics are ordered by correlation to the experi-
mental values.
AutoDock 4.2.3
31. This is a FF-based function, so scores for
the minimized complexes were chosen. We also chose the scores
calculated using the default charges (Gasteiger charges from
AutodockTools 1.5.4.2) over using AM1-BCC charges provided
with the data set because AutoDock is parametrized to use
Gasteiger charges.
AutoDock Vina 1.1.1.1
32. Standard, default scoring options
were chosen, and the protein and ligand were prepared with
AutodockTools 1.5.4.2. Scores calculated with the unminimized
complexes were chosen because this is a knowledge-based
potential.
DOCK 4.0.1
33. This scoring function is based on the AMBER
FF, so scores for the minimized complexes were chosen. Scores
were submitted using both the full DOCK scoring function and
thefunctionwithonlythevdWtermsincluded.Thescorechosen
for the core set used the full scoring function.
DrugScore 1.1
34. The default scoring parameters were used.
Even though this is a knowledge-based function, scores for the
minimized complexes were chosen because they had slightly
better correlation with experimental affinities.
eHiTS
35. The scores chosen for the core set were calculated
with the default scoring options using the minimized set of
structures. A second set of scores was also submitted with the
function tuned on the entire data set. The standard score
provided by eHiTS was chosen over the scores calculated from
thefunctiontrainedonthedataset.However,thescoresfittothe
CSAR-NRC set were used as a type of benchmark because the
large number of parameters allowed for a very tight correlation
to experimental values. This was taken as a limiting case for the
maximal performance possible when fitting to the data set.
FRED 2.2.5 (Chemgauss3)
36. Standard, default scoring was
chosen, calculated with the unminimized complexes because this
is a soft, shape-based scoring method. The AM1-BCC charges
provided with the data set were used. Scores were calculated
using Shapegauss, Chemgauss3, Chemscore, OEChemscore
1.4.2, Screenscore, and PLP scoring functions with a box cutoff
of 4 Å larger than the ligand. Both the minimized and unmini-
mized structures were tested. The Chemgauss3 function using
the unminimized structures was chosen because it achieved the
highestR
2inlinearfittoexperimentfortheCSAR-NRCdataset.
Glide 5.5 (SP)
37. The minimized set of complexes was used
because Glide is based upon the optimized potentials for liquid
simulations (OPLS) FF for atom typing and charges. The grid
was centered at the average ligand coordinate and the box
extended 25 Å. The standard precision (SP) and the extra
precision (XP) scores were calculated. SP was chosen over XP
because it was able to score more of systems in the CSAR-NRC
dataset.Also,SPhadahigherR
2inlinearfittoexperimentforthe
CSAR-NRC data set.
GOLD 4.0.1 (ChemScore)
38,39. The scores of the minimized
structures were chosen for the core set, since the performance
based on R
2 was better. ChemScore was chosen over GoldScore
andASPbecauseithadthebestcorrelationwithexperiment.The
binding site was defined as the region within 12 Å of the ligand’s
center of mass. Non-natural amino acids and water molecules
are not considered in the rescoring. GOLD used primarily
knowledge-based scoring functions (or statistical potential
functions), which relied only on atom typing of the ligands, so
thechargeinformationoftheligandswasnotusedinthescoring.
ITScore2.0
40.Standardscoringwaschosenoverthenewform
thatincludesacorrectionforrotatablebondsintheligand.Scores
calculated for the unminimized complexes were chosen because
thisisaknowledge-basedpotential.ITScorewastrainedon1152
proteinligand complexes from PDBbind
29,30 (excluding those
in the CSAR data set), to develop the pairwise statistical
potentials for the scoring function.
Lead Finder
41. Scores were based on two preparation proto-
cols.ThefirstusedthestructuresprovidedintheCSAR-NRCset
of minimized complexes. In the second, the structures were
prepared using MolTech’s software Model Builder, which calcu-
lates the pKas of the ligand to suggest proper ionization states.
42
Though the second preparation showed a slightly improved
correlation to the experimental values, the scores from the first
preparation were chosen for the core set for consistency with
other methods.
MedusaScore
43. The participant provided two scores based
onMedusaScoreandaQSARmodel.MedusaScoreisaFFbased
function, but the vdW repulsion terms are removed in order to
avoid sensitivity to possible atomic clashes in the structures.
MedusaScore was chosen over the QSAR approach because the
latterwasbasedondescriptorsdeterminedfromtheCSAR-NRC
data set.
MOE2010.10(ASEandAffinityDG)
44.Twoscoringfunctions
from MOE were chosen as core scores because they used
fundamentally different and independent approaches. All MOE
scoring functions (ASE,
45 Alpha HB, London dG, and Affinity
dG) were used with their default settings and were computed on
both the crystal structures and minimized structures provided.
Both ASE and Alpha HB are shape-based methods, and ASE was
chosen because of its better correlation with the experimental
affinities. Both LondonDG and AffinityDG functions attempt
to estimate the free energy of binding. Affinity DG had a lower
RMSE and was chosen for the core set. The chosen core scores
werecalculatedusingtheminimizeddataset,asitprovidedbetter
agreement with experiment in both cases.
M-Score
46. The default scoring parameters were used for this
knowledge-based scoring function. The minimized structures
resulted in scores with slightly better correlation to experiment
and were chosen for the core set.
S2
47. The S2 function is a linear interaction energy function
based on the number of interacting types of pairs, with the
weights calculated using linear regression fit to the LPDB data
set. Scores for the minimized structures were chosen. The S2
functionwaschosenovertheS1functionbecausetheS1function
only accounts for the size of the molecule.
SIE
48.Solvated interaction energy (SIE) scores use a FF-based
method, so the minimized complexes were used. Parameters
were assigned using AMBER/GAFF, but AM1-BCC charges
were used for the ligand, cofactor, and any other modified
residues. Two parameters of the SIE function (R and C) are fit
to experimental binding free energies. The standard approach
used 99 proteinligand complexes. The R and C values were
also refit using the CSAR-NRC data set. The standard scores
provided from the SIE scoring function were chosen over the
scores fit to our data set, to remove any bias and maintain
consistent treatment across all core scores.
X-Score 2.0
49. No special preparation was performed, and
the default scoring parameters were used. X-Score reports three2119 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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scores (HPScore, HMScore, and HSScore) and the average
of all three. We chose the average score for the core set, based
on the minimized set of structures. X-Score was developed from
the PDBbind data set which has significant overlap with the
CSAR-NRC set.
Caveats.Of the 17 core methods above, 12 were able to score
all343 complexes. Twomethods leftonecomplexunscored, and
the other three were unable to score two, four, and five
complexes, respectively. Any complex left unscored was counted
as an outlier for that method. On very rare occasion, we needed
to drop an individual complex from a method’s set of scores
(a single complex was removed from three methods, and three
complexes were removed from one method). In these cases, the
complexes’ scores were well off from the rest of the set, and the
residuals were greater than 3.5σ (very unlikely in a set this size).
These were very likely errors in the calculation, and they greatly
skewed the linear regression analysis outlined below. Of course,
any removed complex was treated the same as an unscored
complex.
Correlation between Scores and Experimental Binding
Affinities. The statistical package “R”
50 was used to calculate
Pearson’s R, Spearman F, and Kendall τ values. Fisher transfor-
mations coupled with standard deviations were used to deter-
mine 95% confidence intervals.
51 Every method was normalized
so that the scaled scores ranged from 0 to 1 (i.e., scores were
converted by first making all scores positive numbers and then
scaling by [(scorei  scoremin)/(scoremax  scoremin)]). This
simply shifts the values and scales them. It does not change the
value of R
2, but it does change any Person’s R, Spearman F,o r
Kendall τ with a negative value to its absolute value. This
treatmentmakesiteasiertocompareacrossthemethodsbecause
R, F,o rτ of 1.0 always indicates perfect correlation and rank
ordering, regardless of whether the original scores were given in
positive or negative numbers.
Selecting BAD and GOOD Complexes by Linear Regres-
sion. Each method’s scores were compared to the experimental
pKd/i through least-squares linear regression analysis in JMP.
52
AsnotedinFigure1,theresidualsarenormallydistributedwithσ
proportional to the goodness of fit. JMP
52 was used to compare
the residuals across all the fits and determine the list of BAD
complexes. These BAD complexes fell into two groups. The
UNDER set consisted of those complexes with residuals g1σ
(under scored) in at least 12 of 17 functions, and the OVER set
were those with residuals e1σ (over scored) in at least 12 of
the 17 functions. Before progressing to the comparison of BAD
and GOOD complexes, we searched the literature to identify
whether any subsequent research on those targets had identified
anyerrorsintheprocessingordisagreementsinaffinitymeasure-
ments.Noerrors insetuporchangestoaffinitydatawerefound.
WhenidentifyingtheGOODstructures,wewantedtoremove
anybiasinthelinearregressionarisingfromtryingtoﬁttheBAD
complexes. Therefore, the BAD structures were removed, and
then theremainingcomplexeswereﬁtagain inJMP.
52The set of
GOODcomplexeswasdeﬁnedasthosewithanabsolutevalueof
itsresiduallessthan1.1pKd/i(<1.5kcal/mol)inatleast12ofthe
17 core scoring functions.
Comparison between the Physical Properties of BAD
and GOOD Sets. We calculated over 400 physicochemical
properties for each complex based on the ligand, the protein,
andtheinteractionsbetweenthetwo.Fortheligand,alltwo-and
three-dimensional (2D and 3D) properties available in MOE
44
were calculated, except for those requiring semiempirical
quantum mechanics. Energy descriptors were calculated with
the MMFF94x force field in MOE. This provided 319 ligand
descriptors.
The proteins, binding sites, and the proteinligand interac-
tions were examined in many ways. Properties describing the
qualityofthecrystalstructureincludedclashscorescalculatedby
MolProbity,
53allZscorescalculatedby WhatIf,
54DPI,
55and the
Rfree and resolution reported in the original publication for each
complex. The chemical interactions between the ligand and the
protein were determined by the prolig_Calculate function avail-
able in MOE,
44 which yielded hydrogen-bonding, ionic, arene,
and metal interactions within the binding sites. The buried and
exposed molecular surface area (SA) of the binding pocket
was calculated with GoCav.
56 The hydrophobic buried SA was
estimated by determining which nonhydrogen atom of the
protein was closest to the buried surface grid point determined
by GoCav. If a carbon atom of the protein or the sulfur atom of a
methionine residue was closest, then the point was considered
hydrophobic. All other buried SA points were considered
hydrophilic. Bridging water molecules were required to be less
than50%solventexposedandtobewithin4Åofanonhydrogen
atom of both the ligand and the protein. Any natural amino acid,
modiﬁed residue, and metal atom with a nonhydrogen atom
within 4 Å of the ligand’s nonhydrogen atoms were considered
part of the protein’s binding site. These contacts were deter-
mined and tallied using in-house code written in Perl. Each
binding site was then described by its %amino-acid content
(numberofeachofthe20aminoacidsinthebindingsitedivided
by the total number in the binding site, where metals and
modiﬁed residues were counted as a 21st residue called “other”).
Then averages and standard deviations for the amino acid
content of the binding sites were determined by bootstrapping
for 1000 iterations, randomly combining two-thirds of the data
set each time. GOOD, OVER, and UNDER complexes were
each bootstrapped as separate sets.
For every physicochemical property, JMP
52 was used to
compare the distribution of values for the GOOD complexes
tothedistributionofvaluesfortheBADcomplexes.UNDERand
OVER complexes were compared separately to the GOOD
complexes.Anonparametric,two-tailed,Wilcoxonrank-sumtest
was performed to calculate the likelihood that distributions of
physicochemical properties were the same. Only properties with
p values e0.05 were considered relevant.
’RESULTS AND DISCUSSION
Factor Xa (FXa) Complexes Were Removed Early in the
Analysis. The initial set of identified outliers contained several
FXa structures. Each had ligands with sub-nM-level affinities,
but the pockets were well exposed and the complementarity
appeared poor. All FXa structures are missing an N-terminal
domain, and its effect on ligand binding is unclear. In vivo,
the domain is required for calcium activation of FXa, and the
anticoagulant warfarin works by inhibiting the modification of
this domain’s key residues that chelate calcium.
57 Therefore, we
removed all 11 FXa structures from the analysis of BAD and
GOOD structures.
The subsequent analysis below is based on the 332 remaining
structures in the CSAR-NRC set. Note that after dropping these
complexes, the characteristics of the set are basically unchanged.
Themaximumandminimumaﬃnitiesarethesame.Theaverage
and median aﬃnities of the 332 set are 6.07 and 6.115 pKd/i,2120 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
Journal of Chemical Information and Modeling ARTICLE
respectively. The standard deviation is 2.20 pKd/i, and the
median unsigned error (Med |Err|) is 1.47 pKd/i. The distribu-
tionisstillGaussianwithnear-zeroskewandkurtosisof0.09and
0.04, respectively.
However, FXa has been a platform for successful structure-
baseddesign
58andtestingofmodelingtechniques.
59,60Thereisa
wealth of additional data on FXa in the pharmaceutical
industry
6169 that would help the ﬁeld overcome its limitations.
In fact, we are currently negotiating with two companies for FXa
data. There are strong electronic inﬂuences and ππ stacking
eﬀects that can shift ligand aﬃnities over 4 orders of magnitude.
Structure 2p3t
67 (set 1, complex no. 141) is a good example of
the diﬃculty in modeling some high-aﬃnity inhibitors of FXa.
It has a binding aﬃnity of 5 pM but appears to have poor
complementarity and is largely solvent exposed, see Figure 2.
The eﬀects of halogenation and ππ stacking provide a strong
driving force for the association. Below, we show that hydro-
phobic interactions in tight-binding complexes are underesti-
mated by the majority of methods examined in the benchmark
exercise.
It should be noted that several structures of HIV-1 protease
were in the BAD set. At the same time, there were twice as many
in the GOOD set, and the complete protein is present in the
crystal structures. Therefore, we chose not to eliminate those
complexes from the analysis. A table in the Supporting Informa-
tionliststheproteinsthathaveanappropriateligandseriesinthe
data set, including FXa. Proteins were clustered at 100% se-
quence identity to avoid data on mutants muddling the analysis
of aﬃnities. Sixteen proteins (listed with PDB ids in the data
set paper)
3 had three ligands or more, but only 10 had ligand
aﬃnities that ranged more than 1 order of magnitude. No limit
was placed on chemical similarity across the ligands to deﬁne
somemeasureofcongenericseries,thoughsomeclearlyare.Each
code’s relative ranking of the ligand series for each of the 10
proteins is also provided in the table in the Supporting Informa-
tion. A list of all protein families and their complexes has been
included in the download of the data set since the project was
initiated (www.CSARdock.org, accessed July 25, 2011).
Correlation between Experimental Affinities and the 17
Core Methods. Table 1 presents both parametric and nonpara-
metric assessments of the correlation between the submitted
scores and the experimental binding affinities of the 332 entries
Figure 2. Crystal structure of FXa bound with a 5 pM ligand (PDB id
2p3t). The ligand is very exposed with few hydrogen bonds to the
protein.
Table 1. Parametric and Nonparametric Measures of Correlation Between the Scores and Experimental Binding Aﬃnities
a
method Pearson R Spearman F Kendall τ R
2 σ
b RMSE
b Med |Err|
b
code 1 0.76 (0.800.71) 0.74 (0.790.68) 0.55 (0.600.50) 0.58 (0.640.50) 1.43 1.51 1.00
code 2 0.72 (0.770.66) 0.73 (0.780.67) 0.54 (0.590.49) 0.52 (0.590.44) 1.53
code 3 0.67 (0.720.60) 0.68 (0.740.61) 0.49 (0.540.43) 0.45 (0.520.37) 1.64 1.65 1.05
code 4 0.64 (0.700.58) 0.64 (0.700.56) 0.46 (0.520.40) 0.42 (0.490.33) 1.68 2.09 1.5
code 5 0.63 (0.690.56) 0.64 (0.710.57) 0.46 (0.520.40) 0.40 (0.480.32) 1.71
code 6 0.62 (0.680.55) 0.61 (0.680.53) 0.43 (0.490.38) 0.39 (0.470.30) 1.72 1.81 1.26
code 7 0.62 (0.680.55) 0.61 (0.680.53) 0.43 (0.490.37) 0.38 (0.460.30) 1.72
code 8 0.61 (0.670.54) 0.59 (0.660.51) 0.42 (0.480.36) 0.37 (0.450.29) 1.75
code 9 0.61 (0.670.53) 0.60 (0.670.52) 0.43 (0.490.37) 0.37 (0.450.28) 1.75
code 10 0.60 (0.660.52) 0.60 (0.670.52) 0.43 (0.480.37) 0.36 (0.440.27) 1.77 2.99 1.67
code 11 0.59 (0.660.52) 0.57 (0.640.49) 0.40 (0.460.34) 0.35 (0.430.27) 1.77 1.92 1.36
code 12 0.57 (0.630.49) 0.57 (0.650.49) 0.41 (0.470.35) 0.32 (0.400.24) 1.82 2.18 1.28
code 13 0.56 (0.630.48) 0.60 (0.670.52) 0.42 (0.480.36) 0.32 (0.400.24) 1.82 2.52 1.68
code 14 0.56 (0.630.48) 0.54 (0.620.45) 0.38 (0.440.31) 0.32 (0.400.23) 1.82
code 15 0.56 (0.630.48) 0.56 (0.630.47) 0.39 (0.450.33) 0.31 (0.390.23) 1.83
code 16 0.53 (0.600.45) 0.53 (0.610.44) 0.37 (0.430.31) 0.28 (0.360.20) 1.87 1.90 1.23
code 17 0.35 (0.440.25) 0.37 (0.460.27) 0.25 (0.320.18) 0.12 (0.200.06) 2.07
Yardsticks (Maximum and “Null” Correlations)
trained on 343 set
c 0.93 (0.940.91) 0.93 (0.940.90) 0.77 (0.800.74) 0.86 (0.890.83) 0.82 0.95 0.48
heavy atoms 0.51 (0.580.42) 0.49 (0.570.40) 0.35 (0.410.28) 0.26 (0.340.18) 1.90
SlogP 0.46 (0.540.38) 0.50 (0.580.41) 0.34 (0.400.28) 0.22 (0.300.14) 1.95
aValues obtained through analysis of the set of 332 complexes (FXa structures removed from the CSAR-NRC set). 95% conﬁdence interval in
parentheses, units of pKd for σ, RMSE, and Med |Err|.
bMetrics appropriate for the methods that estimated absolute binding aﬃnities, rather than
relativeranking;unitsarepKd.
cOneofthe17methodsabove,ﬁtwithmanyadjustableparametersspeciﬁcallytoreproducethe343complexesofthefull
CSAR-NRC set.2121 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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used. For methods that estimated affinities, the Med |Err| was
1.001.68 pKd/i (1.42.3 kcal/mol), and the RMSE ranged
from 1.51 to 2.99 pKd/i (2.14.1 kcal/mol). Across all 17 core
scores, the σ values for the residuals from the linear regression
were1.432.07pKd/i(1.92.9kcal/mol).ForFF-based,knowl-
edge-based, and empirical scoring functions, all had examples
with high and low correlation. There was no obvious advantage
to choosing one type over another.
Modest correlations were expected because of the diﬃculty in
predicting absolute free energies of binding, but the correlations
arejustasgoodasthosefortheeasierproblemofrelativeranking
to a single protein target.
2 Spearman F and Kendall τ are
nonparametric and reﬂect the relative ranking across the com-
plexes, with F nearlyequaling the Pearson R values (0.760.35),
while τ is less.
TheR
2rangeis0.580.12withthebulkofthemethodsfalling
between 0.4 and 0.3. Caution must be used in making a
statistically signiﬁcant evaluation across the codes. Though a
95% conﬁdence interval of R
2 can be analytically determined,
51
the diﬀerence in the 95% conﬁdence intervals is not the same
as a 95% conﬁdence in the diﬀerence. It is most appropriate to
evaluate the statistical signiﬁcance between the R
2 values by
examining the residuals that underlie the correlation. As shown
in Figure 1, residuals for all ﬁts are normally distributed around
zero,soarank-sumtestisnotappropriate.Instead,thediﬀerence
in the spread of the distribution can be evaluated using Levene’s
F-test for the equality of variance (calculated using the “R”
statisticalpackage).
50Thisismorestringentthansimplycompar-
ing the conﬁdence intervals. Codes 1 and 3 have a small overlap
in their 95% conﬁdence intervals of R
2, but the F-test of their
residuals provides a p value of 0.015, meaning that they are
statisticallysigniﬁcantintheirdiﬀerence.(Levene’stestsforcode
3 show it to be statistically comparable to codes 2 and 411, but
it is a method parametrized on the PDBbind data set,
29,30 which
has a great deal of overlap with the CSAR-NRC set. A “perfor-
mance” comparison to other methods is not particularly mean-
ingful.) Levene’s test for the residuals of codes 1 and 2 gives p =
0.23;therefore,theperformanceofcodes1and2arecomparable.
F-test comparisons of codes 416 have p > 0.05, making them
equivalent. The very low R
2 for code 17 is statistically signiﬁcant
in its diﬀerence to the other core methods.
Yardsticks for Linear Regression. The equivalence of the
overwhelming majority of methods further underscores why
the benchmark exercise is not a contest. More importantly, only
codes 16 are statistically significant in their difference to
common “null cases.” Perhaps the most appropriate null case
for scoring functions is the correlation between affinity and the
number of nonhydrogen atoms in the ligand,
70,71 which is R
2 =
0.26 for this set with a 95% confidence interval of 0.340.18.
This is a particularly useful counter example because the additive,
pairwise potentials used in most scoring functions lead to ever
increasing scores as more atoms are added to the ligand.
7072
Anothernullcasetoconsideristhecorrelationbetweentheaffinity
and the hydrophobicity of a ligand. It is well-known that adding
hydrophobic moieties to a ligand will increase its affinity.
7375
This is a bit of a “cheat” because one is simply disfavoring the
unboundstate.WehaveusedSlogPvalues
76calculatedwithMOE
toprovidethisnullcase(R
2=0.22witha95%confidenceinterval
of0.300.14).Weshouldcautionthereaderthat,unlikethecount
of nonhydrogen atoms, predictions of hydrophobicity are para-
metrizedmethodsjustlikescoringfunctions,exceptthatthevalues
are independent of the protein target.
Weshouldnotethatthehighestcorrelationtoexperimentwas
obtained when the method with the most adjustable parameters
was reﬁt using the 343 CSAR-NRC complexes: R
2 = 0.86, R =
0.93, F = 0.93, and τ = 0.77. This is provided in Table 1 as an
example of maximum performance possible with the data set. As
our paper on the data set noted, the experimental uncertainty
shouldlimitthecorrelationtoanR
2of∼0.83whenﬁttingtothis
data without overparameterizing.
3 Of the 64 total submissions, 4
othersalsoﬁttothewhole dataset,obtaining R
2of0.540.42,R
of 0.730.64, F of 0.710.64, and τ of 0.520.46.
Identification of 63 BAD and 123 GOOD Complexes
by Linear Regression and σ. A complete list of the BAD and
GOOD complexes is given in the Supporting Information.
Figure 3 compares the 17 core scoring functions to the experi-
mentalaffinities.Theredlineshighlightcomplexeswithresiduals
within and outside (1σ, where any point outside is an outlier
for that individual method. The BAD complexes, defined by
having residuals outside (1σ for at least 12 of 17 methods, were
composed of 34 OVER (weak binders scored too high) and 29
UNDER (strong binders scored too low). Figure 3 shows that
everymethodmayscoreafewBADcomplexeswell(redandblue
data points between the red lines).
From the linear regression of the 332 complexes, 116 had
residuals within (1.1 pKd/i (1.5 kcal/mol) for g12 of 17
methods. However, it is best to keep the BAD structures from
inﬂuencingthelinearregression andsubsequentidentiﬁcationof
GOOD systems. Therefore, we removed the 63 BAD complexes
andreﬁttheremaining269complexesforeachmethod.Basedon
theg12of17requirement,thenumberofsystemswithresiduals
within(1.1pKd/iincreasedto123.TheSupportingInformation
outlinestheprocedureinaﬁgureandprovidesadiscussionofour
metrics for identifying the GOOD complexes.
Methods that Estimate Absolute Binding Affinities. Nine
of the core methods estimated binding affinities, rather than
providingsimplerankscores.TheMed|Err|rangedfrom1.00to
1.68pKd/i,andtheRMSEwas1.512.99pKd/i,seeTable1.The
agreementwithexperimentrankedthecodesintheorder(1,3)>
(16, 6) > (11, 12, 4) > (13, 10). For this ranking, greater
importancewasgiventoMed|Err|becauseRMSEheavilyweighs
the farthest outliers. For estimates of affinities, having less error
for more complexes is more important than having outliers that
are closer but still quite far off.
A suggested null case is to calculate the RMSE and Med |Err|
while setting every score to the average experimental value
(6.07pKd/i).ForRMSE,thatsimplygivesthestandarddeviation
of the data set, 2.2 pKd/i, and the Med |Err| is 1.47 pKd/i. Five of
the 9 methods have RMSE and Med |Err| less than the null case
(codes 1, 3, 16, 6, and 11). Two methods have errors less than
one null metric but nearly equal to the other (codes 12 and 4).
Twomethodshaveerrorsinexcessofthenullcase(codes13and
10). Of course, all of the methods have RMSE larger than their
standard deviation from the linear regression, but it is most
pronounced for codes 10 and 13 which seem to be biased to
overscore and underscore, respectively, across the full range of
complexes (see Figure 4). Codes 3 and 16 rank very well and
havelow errors, but they appear tohavesome bias thatlimitsthe
scoring range to roughly 410 pKd.
Figure 4 compares the estimated aﬃnities with the experi-
mental values for these nine core methods, where any estimated
freeenergieswereconvertedtopKd.Wehaveidentiﬁeduniversal
outliers much as we did through linear regression. Using RMSE
for a cutoﬀ would parallel the previous analysis, but as stated2122 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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Figure 3. Least-squares linear regression of the 17 core scoring functions. Black lines are the linear regression ﬁt. Red lines indicate +σ and σ, the
standard deviation of the residuals. Blue points are UNDER complexes which were underscored in g12 of the 17 functions. The red points are OVER
complexes which were overscored in g12 of the 17 functions.2123 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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above, low Med |Err| is more important in this type of scoring.
OVER complexes had errors (pKd/i
experiment  pKd
score) less
than 1  Med |Err| in at least 7 of the 9 functions (78% of the
methods, a larger percentage than the 12 of 17 requirement for
the sets deﬁned by linear regression). UNDER complexes were
determined by the errors greater than 1  Med |Err| for g7o f9
methods. Again, structures were determined to be well scored if
their error was <1.1 pKd. This cutoﬀ was maintained even if the
Med |Err| was less than 1.1. This lead to 36 OVER, 28 UNDER,
and 34 GOOD complexes based on Med |Err|. Unfortunately,
there is no way to estimate the statistical signiﬁcance of the sets
determined in this manner, but the overwhelming majority of
complexes are also in the sets determined by linear regression.
The complexes are listed in the Supporting Information.
Comparison of the GOOD versus BAD Complexes. The
comparison of GOOD and BAD complexes below focuses only
on the sets determined through linear regression because of the
solid statistics outlined in the Introduction Section. We next
applied the concept of a null hypothesis to this portion of the
analysis and developed a null set of complexes (NULL) to
characterize a type of signal-to-noise metric. The first graph in
Figure 5 shows the distribution of affinities for the GOOD,
OVER, and UNDER sets. There is a large bias for OVER
complexes to have low affinities, UNDER complexes to have
high affinities, and GOOD complexes to lie in between. There-
fore, we defined the NULL cases based on affinities and
compared the characteristics of the signal to the inherent back-
ground. Within this framework, the signal is the comparison of
GOOD to OVER and UNDER complexes, and the NULL sets
simplycomparecomplexeswithmidlevelaffinitytoweakbinders
and tight binders, respectively. First, we divided the 332 com-
plexes into three subsets, using cutoffs of e50 nM and g50 μM,
as shown in gray shading in Figure 5. We then removed any
UNDER complexes from the high-affinity subset, any GOOD
complexes from the midrange subset, and any OVER complexes
from the low-affinity subset. The NULL set contained 179
complexes: 65 high-, 69 mid-, 45 low-affinity complexes. We
wouldliketoensurethatthedifferencesinphysicalpropertiesare
notsimplyareflectionofaffinity.Obviously, thosepropertiesare
important in scoring and will be represented across the sets, but
theuseofaNULLsethelpsusidentifypotentialbiasarisingfrom
the definition of a difficult-to-score system.
Figure4. Comparisonofexperimentalandcalculatedvaluesfromtheninefunctionswhichpredictedabsolutebindingaﬃnity,listedroughlyinorderof
increasing Med |Err| and RMSE. Black lines represent perfect agreement. The red lines indicate +Med |Err| and Med |Err| from the black line. The
bluecirclesdenotecomplexesforwhichg7ofthe9methodshaveconsistentlyunderestimatedtheaﬃnitybyatleastMed|Err|,whiletheredcirclesare
those where the aﬃnity was overestimated.2124 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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Our goal in this analysis is to identify the physical character-
istics of the proteins and the ligands that are most diﬃcult to
model.However,wecannotbasethisdeterminationsolelyonthe
properties of the BAD complexes; they must be compared to the
GOOD complexes. Any properties common to both sets cannot
be the root of the problem. We need to identify characteristics of
diﬃcult systems that are signiﬁcantly diﬀerent from the easy
ones. For instance, there are studies in the literature indicating
that metalloenzymes are diﬃcult to model,
7779 and if many of
theBADscontainedmetalsintheirbindingsites,thenitwouldbe
temptingtoconcludethatmetalsareamajorstumblingblockfor
our ﬁeld. However, that would not be true if many metallo-
enzymes were also in the GOOD set. We can easily calculate
p values for diﬀerences in the distributions of various system
propertiesinGOODvsOVERandGOODvsUNDERsets.This
allows us to identify statistically signiﬁcant diﬀerences between
the sets. In fact, we found that there is no diﬀerence between
GOOD, OVER, or UNDER complexes with respect to metals
in the binding sites (medians of 0 for all three sets; means of
0.32 for GOOD, 0.24 for OVER, and 0.24 for UNDER; p values
of 0.85 for OVER vs GOOD and 0.79 for UNDER vs GOOD).
Of course, this does not mean that metalloenzymes are easy to
model;thatwouldrequireabiasformetalsinGOODonly.Itwas
interesting to ﬁnd that there was a statistically signiﬁcant bias for
metalsinthebindingsitesoflow-aﬃnitycomplexesintheNULL
sets (mean of 0.62 for midrange and 1.11 for low with p = 0.03).
Having a bias in the NULL set that is not found in the OVER vs
GOOD comparison further supports the ﬁnding that metals are
not a strong inﬂuence on BAD complexes. It should be empha-
sizedthatthisﬁndingisforageneralanalysisovermanymethods,
and it is still possible that an individual scoring technique could
ﬁnd metals to be its greatest limitation (this was the ﬁnding of
one participating group that was unable to submit a paper to this
special issue).
Table 2 lists the most relevant physicochemical properties
of the ligands and pockets of the GOOD, UNDER, OVER, and
NULLsets.Mediansandpvaluesforeachpropertyareprovided.
Physicochemical Properties of GOOD versus UNDER
Complexes. Very few statistically significant differences were
observed between properties of the GOOD and UNDER sets.
Theirligandsareroughlythesamesize,whichisinstarkdisagree-
ment with the NULL case. Manyphysicochemicalproperties are
proportionaltosize,sothefactthatUNDERandGOODligands
are similar in size makes our key comparisons between the sets
more straightforward. However, comparisons to the NULL case
must be done cautiously because high-affinity NULLs are much
larger. Therefore, all properties were examined by the raw values
and values corrected for size by dividing by the number of ligand
heavy atoms (HA).
A striking diﬀerence between GOOD and UNDER ligands is
the fact that both have roughly the same number of rotatable
bonds (Nrot and Nrot/HA), but UNDERs have much lower
torsional energies (Etor). There is less torsional strain in the
UNDER ligands. Even when corrected for size (Etor/Nrot),
UNDERs are less strained than the high-aﬃnity ligands in the
NULL case.
Lipinski
80 and Oprea
81 described various counts of calculated
properties that aid in indentifying compounds with good oral
absorption (Lipinski) and drug-like compounds (Oprea). A
count of the number of ligands in each set that violate these
empirical rules shows that UNDER ligands are more drug-like
than the GOOD ligands and the high-aﬃnity set in the NULL
case. UNDERs are more lipophilic than GOODs (higher SlogP
and lower logS), but the diﬀerence is more pronounced in the
NULL case. The counts of hydrophobic and hydrogen-bonding
atoms are not signiﬁcantly diﬀerent between UNDER and
GOOD ligands, unlike the NULL case. What is most striking is
that—despite the ligands being roughly the same size with the
same number of hydrogen-bonding features—there are signiﬁ-
cantly fewer hydrogen bonds between the protein and the ligand
in UNDER complexes. The pockets of UNDER complexes
contain fewer water molecules as well. Many of the trends for
hydrogenbondingindicateamorehydrophobicenvironmentfor
theUNDERpocketsbutjustmissthearbitrarycutoﬀofp=0.05.
There is signiﬁcantly less hydrophilic buried surface area (BSA)
Figure 5. Distribution of binding aﬃnities in the GOOD and BAD
complexes (left) are compared to those of the NULL case (right). The
NULL case is generated by the sets of all complexes with aﬃnities
e50 nM (high), 50 nM50 μM (middle), and g50 μM (low). This
midrangeofaﬃnitiesishighlightedwithawide,graybaronbothﬁgures.2125 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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in the UNDER pockets, which shifts the %hydrophilic and %
hydrophobic BSA. It is unclear if these trends in the pocket BSA
are a reﬂection of the NULL case because the GOOD and
UNDER ligands are very similar, whereas the mid- and high-
aﬃnity sets are starkly diﬀerent. In the same vein, the hydro-
phobic vdW surface per HA of the ligand is larger for UNDERs,
but it is also similar to the value obtained for the high-aﬃnity
complexes in the NULL set.
Physicochemical Properties of GOOD versus OVER Com-
plexes. Like the UNDERs, OVER ligands are roughly the same
size as the GOOD ligands. There is a large size difference in the
NULL case, but with low-affinity ligands being much smaller
than the midrange, so again, comparisons to the NULL must be
made cautiously.
OVER complexes have two patterns in opposition to the
UNDER complexes. OVER ligands have higher Etor/Nrot,
making them more strained. Also, OVER ligands are much more
hydrophilic and soluble than GOOD (or UNDER) complexes.
While the UNDER ligands had no diﬀerences in the count of
hydrophobic and hydrophilic atoms, the OVER ligands are very
diﬀerent from the GOOD. There are fewer hydrophobic atoms
and notably more oxygen atoms. On a per HA basis, there are
more proteinligand hydrogen bonds and more bridging water.
The ligands have less hydrophobic vdW SA/HA and more polar
vdW SA/HA. For the pockets, the hydrophilic BSA increases
roughlythesamedegreeastheUNDERcomplexesdecrease,but
the p value is just shy of the 0.05 cutoﬀ.
In the NULL case of mid- vs low-aﬃnity complexes, there are
many SA properties that are signiﬁcantly diﬀerent, but many are
due to the large size diﬀerence in the NULL case that is not seen
inOVERvsGOOD complexes. Thereisoneinterestingtrend in
the pockets of the NULL case. The low-aﬃnity complexes have
moreexposedligands(ESA/HA).ThoughtheOVERcomplexes
are more exposed than the GOOD, it is not statistically sig-
niﬁcant nor is it as extreme as the trend in the NULLs.
Comparison of Amino Acids in the Binding Sites. Figure 6
shows the distribution of amino acids in the binding sites of
GOOD, UNDER, OVER, and NULL sets. The comparison of
UNDER to GOOD binding sites shows that the increase in
hydrophobic character of the pockets comes from a marked
increase in the aliphatic residues Val, Ile, and Leu and not a
change in the aromatic amino acids. However, large contribu-
tions from Ile and Leu are also seen in high-affinity NULLs. The
decrease in hydrogen-bonding interactions and hydrophilic BSA
for UNDER complexes comes from significant decreases in Lys,
Arg, and Ser. It is very interesting that there is a decrease in the
positively charged residues but not the presence of the acidic
amino acids. While there is a decrease in Asn and Gln, this is also
seen in the NULL set.
The comparison between physicochemical properties of
OVERandGOODcomplexesrevealedmorehydrophilicligands
and pockets for the OVERs. However, the only signiﬁcant
diﬀerence in the composition of the binding sites is more Ser
intheOVERpockets.TherearedecreasesinGlyandIle,butthey
are in good agreement with the content of low-aﬃnity NULL
pockets. It is possible that the similarity in the amino-acid
composition may explain why the OVERs score too well. The
ligands are the same size as GOOD ligands, not small like the
low-aﬃnity NULL ligands, and the pockets are more similar to
GOODs than to the NULLs.
Impact on CSAR’s Future Data Sets. CSAR’s goal is to
provide better, more complete data to the computational
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community, a widely available resource that scientists can use to
improve their docking and scoring methods. This analysis across
allparticipantsinthefirstbenchmarkexerciseisintendedtoshed
light on the most pressing needs of the field as a whole. It is clear
that hydrogen-bonding features should be our immediate focus,
followed by rotatable bonds.
Our comparison of GOOD and BAD complexes shows
that the ﬁeld is underestimating the impact of hydrophobic
Figure 6. Distribution of amino acids in the binding sites of the GOOD and BAD complexes meeting the g12 of 17 deﬁnition (left) are compared to
those of the NULL case (right). The graph in the lower left provides the distribution of all amino acids in the full protein sequences to show that the
important trends do not result from inherent diﬀerences in composition of the proteins (the same is true of the NULLs, data not shown). Metals and
modiﬁed residues are denoted as other, “OTH”. Averages and error bars for the amino acid content were determined by bootstrapping.2128 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
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interactions and overestimating the contribution of hydrogen
bonding. This was supported by the contributions of three
participants who showed that the correlation to aﬃnity was
unchanged or improved when hydrogen-bonding/Coulombic
interactions were removed from their chosen scoring functions
(data not shown). Scoring is usually based only on the bound
complex, but binding is an equilibrium between bound and
unbound states. A hydroxyl group can be added to a ligand to
improve its interaction with a binding site, but experiment often
shows little change in aﬃnity.
82 The added hydrogen bonding
alsofavorstheinteraction withwaterintheunboundstate,andit
is very diﬃcult for a binding site to provide better hydrogen
bondingthanwater.Theelectrostaticinteractionsinmostscoring
functions provide very favorable contributions to the estimated
aﬃnity because desolvation penalties are often overlooked.
Desolvation is also an important driving force for hydrophobic
association, providing a boost that simple vdW energies cannot
model.
It is important that we provide data for many diﬀerent protein
targets.Theaﬃnitiesoftheligandsmustrangeatleast3ordersof
magnitude so that experimental error will not limit the develop-
ment of statistically meaningful models.
83 For each protein, we
wanttoprovidedataonatleastthreecongenericseriesofligands
which provide the widest range of hydrogen-bonding features
possible for the target. This should have a higher impact
than varying size of the ligands. Of course, the data needed to
tacklerotatablebondswilllikelyrequireligandserieswitharange
of sizes.
Our in-house eﬀorts to enhance available data include iso-
thermal titration calorimetry (ITC) and the determination of
binding kinetics (www.CSARdock.org). These complementary
techniques are independent means of determining exact binding
constants,asopposedtoinhibitionconstantsorIC50s.Theyeach
provide valuable insights into the contributions to binding:
entropyandenthalpyforcalorimetryandkonandkoﬀforkinetics.
These data are particularly important for understanding the
hydrophobic eﬀects and hydrogen bonding implicated here.
Furthermore, ITC can be used to determine changes in proton-
ation states upon ligand binding.
84 This complication is a factor
for a few of the BAD complexes. For instance, the crystal
structure 1tok
85 (set 2, complex no. 96) is aspartate transferase
binding maleic acid (HOOCHCdCHCOOH). In the bind-
ing site, both ends of the diacid are complemented by bidentate
hydrogen bonding from Arg side chains, indicating that the
ligand is doubly deprotonated. However, maleic acid can be
singly deprotonated in solution, depending on the conditions
(second pKa of maleic acid is ∼6.3).
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’CONCLUSION
The most common test to evaluate docking and scoring
involves relatively ranking compounds against a single target
because pharma tackles this practical challenge every day. How-
ever, the ﬁndings of those exercises are often system-dependent
and cannot necessarily be extrapolated. Tackling absolute free
energiesofbindingacrossdiverseproteinsisdiﬃcult,butwehave
the potential to learn something new by posing unique chal-
lenges. We have outlined a means for statistically evaluating our
data set across multiple methods, emphasizing the insights
possible by combining the results of many participants.
These insights help us prioritize the design of new data sets
to address speciﬁc shortcomings of our methods. If the answer
could be found by conducting individual, single-target studies,
then the solutions would have been found long ago. It is
important to keep an eye on the big picture—the global land-
scape of docking and scoring—to understand what model
systems are most needed to improve the ﬁeld.
Future benchmarks from CSAR will involve blind rankings of
chosen model systems, sets of data designed to address the
shortcomings we identify as a community. As always, we will
strive to provide as many systems as possible to avoid system-
dependent insights. Conﬁrmed data on inactive compounds will
be provided. We greatly appreciate the eﬀorts of all of our
colleagues in the pharmaceutical industry for the donation of
data for these future benchmark exercises.
’ASSOCIATED CONTENT
b S Supporting Information. Table of 10 proteins with
ligand series and the performance of each of the 17 core codes
on relative ranking, a discussion of methods and metrics for
identifying the GOOD complexes, and a complete listing of
GOOD and BAD complexes. This material is available free of
charge via the Internet at http://pubs.acs.org.
’AUTHOR INFORMATION
Corresponding Author
*E-mail: carlsonh@umich.edu. Telephone: (734) 615-6841.
’ACKNOWLEDGMENT
We would like to thank all participants in the benchmark
exercise! Whether you submitted a paper to this special issue,
gave a talk at the symposium, submitted scores for this analysis,
or just attended the talks and the discussions at the symposium,
everyone’s feedback was valuable to our eﬀorts. We thank
numerous colleagues for helpful discussions, particularly John
Liebeschuetz (CCDC) for his insights in Factor Xa. The CSAR
Center is funded by the National Institute of General Medical
Sciences (U01 GM086873). We also thank the Chemical
Computing Group and OpenEye Scientiﬁc Software for gener-
ously donating the use of their software.
’REFERENCES
(1) Leach, A. R.; Shoichet, B. K.; Peishoﬀ, C. E. Prediction of
protein-ligand interactions. Docking and scoring: successes and gaps.
J. Med. Chem. 2006, 49, 5851–5855.
(2) Warren, G. L.; Andrews, C. W.; Capelli, A.-M.; Clarke, B.;
LaLonde, J.; Lambert, M. H.; Lindvall, M.; Nevins, N.; Semus, S. F.;
Senger, S.; Tedesco, G.; Wall, I. D.; Woolven, J. M.; Peishoﬀ, C. E.;
Head, M. S. A critical assessment of docking programs and scoring
functions. J. Med. Chem. 2006, 49, 5912–5931.
(3) Dunbar, J. B., Jr.; Smith, R. D.; Yang, C. Y.; Ung, P. M.; Lexa,
K. W.; Khazanov, N. A.; Stuckey, J. A.; Wang, S.; Carlson, H. A. CSAR
Benchmark Exercise of2010: Selectionof the protein-ligand complexes.
J. Chem. Inf. Model. 2011, DOI: 10.1021/ci200082t.
(4) Wang,R.;Lu,Y.; Wang,S.Comparative evaluation of11scoring
functions for molecular docking. J. Med. Chem. 2003, 46, 2287–2303.
(5) Muchmore,S.W.;Debe,D.A.; Metz,J.T.;Brown,S.P.;Martin,
Y. C.; Hajduk, P. J. Application of belief theory to similarity data fusion
for use in analog searching and lead hopping. J. Chem. Inf. Model. 2008,
48, 941–948.
(6) Muchmore, S. W.; Edmunds, J. J.; Stewart, K. D.; Hajduk, P. J.
Cheminformatic tools for medicinal chemists. J. Med. Chem. 2010,
53, 4830–4841.2129 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
Journal of Chemical Information and Modeling ARTICLE
(7) Swann,S.L.;Brown,S.P.;Muchmore,S.W.;Patel,H.;Merta,P.;
Locklear, J.; Hajduk, P. J. A uniﬁed, probabilistic framework for
structure- and ligand-based virtual screening. J. Med. Chem. 2011,
54, 1223–1232.
(8) Baber, J. C.; Shirley, W. A.; Gao, Y.; Feher, M. The use of
consensus scoring in ligand-based virtual screening. J. Chem. Inf. Model.
2006, 46, 277–288.
(9) Bar-Haim, S.; Aharon, A.; Ben-Moshe, T.; Marantz, Y.;
Senderowitz, H. SeleX-CS: a new consensus scoring algorithm for hit
discovery and lead optimization. J. Chem. Inf. Model. 2009, 49, 623–633.
(10) Betzi, S.; Suhre, K.; Chetrit, B.; Guerlesquin, F.; Morelli, X.
GFscore: a general nonlinear consensus scoring function for high-
throughput docking. J. Chem. Inf. Model. 2006, 46, 1704–1712.
(11) Bissantz, C.; Folkers, G.; Rognan, D. Protein-based virtual
screening of chemical databases. 1. Evaluation of diﬀerent docking/
scoring combinations. J. Med. Chem. 2000, 43, 4759–4767.
(12) Charifson, P. S.; Corkery, J. J.; Murcko, M. A.; Walters, W. P.
Consensus scoring: A method for obtaining improved hit rates from
docking databases of three-dimensional structures into proteins. J. Med.
Chem. 1999, 42, 5100–5109.
(13) Clark, R. D.; Strizhev, A.; Leonard, J. M.; Blake, J. F.; Matthew,
J. B. Consensus scoring for ligand/protein interactions. J. Mol. Graphics
Modell. 2002, 20, 281–295.
(14) Feher, M. Consensus scoring for protein-ligand interactions.
Drug Discovery Today 2006, 11, 421–428.
(15) Garcia-Sosa, A. T.; Sild, S.; Maran, U. Design of multi-binding-
site inhibitors, ligand eﬃciency, and consensus screening of avian
inﬂuenza H5N1 wild-type neuraminidase and of the oseltamivir-resis-
tant H274Y variant. J. Chem. Inf. Model. 2008, 48, 2074–2080.
(16) Krovat, E. M.; Langer, T. Impact of scoring functions on
enrichment in docking-based virtual screening: an application study
on renin inhibitors. J. Chem. Inf. Comput. Sci. 2004, 44, 1123–1129.
(17) Oda, A.; Tsuchida, K.; Takakura, T.; Yamaotsu, N.; Hirono, S.
Comparison of consensus scoring strategies for evaluating computa-
tional models of protein-ligand complexes. J. Chem. Inf. Model. 2006,
46, 380–391.
(18) Omigari,K.;Mitomo,D.;Kubota,S.;Nakamura,K.;Fukunishi,
Y.Amethodtoenhancethehitratiobyacombinationofstructure-based
drug screening and ligand-based screening. Adv. Appl. Bioinf. Chem.
2008, 1,1 9 –28.
(19) Paul, N.; Rognan, D. ConsDock: A new program for the
consensus analysisofprotein-ligandinteractions. Proteins:Struct., Funct.,
Bioinf. 2002, 47, 521–533.
(20) Renner, S.; Derksen, S.; Radestock, S.; Morchen, F. Maximum
common binding modes (MCBM): consensus docking scoring using
multiple ligand information and interaction ﬁngerprints. J. Chem. Inf.
Model. 2008, 48, 319–332.
(21) Teramoto, R.; Fukunishi, H. Structure-based virtual screening
with supervised consensus scoring: evaluation of pose prediction and
enrichment factors. J. Chem. Inf. Model. 2008, 48, 747–754.
(22) Teramoto, R.; Fukunishi, H. Consensus scoring with feature
selection for structure-based virtual screening. J. Chem. Inf. Model. 2008,
48, 288–295.
(23) Wang, R.; Wang, S. How does consensus scoring work for
virtuallibraryscreening?Anidealizedcomputerexperiment.J.Chem.Inf.
Comput. Sci. 2001, 41, 1422–1426.
(24) Yang, J. M.; Chen, Y. F.; Shen, T. W.; Kristal, B. S.; Hsu, D. F.
Consensus scoring criteria for improving enrichment in virtual screen-
ing. J. Chem. Inf. Model. 2005, 45, 1134–1146.
(25) Hogg, R. V., Tanis, E. A. Probability and Statistical Inference;
PrenticeHallCollegeDivision:EnglewoodCliﬀs,NJ,2001,pp402411.
(26) Books of Abstracts; 240th American Chemical Society National
Meeting, Boston, MA, August 2228, 2010; ACS: Washington, D.C.,
2010.
(27) Benson, M. L.; Smith, R. D.; Khazanov, N. A.; Dimcheﬀ, B.;
Beaver, J.; Dresslar, P.; Nerothin, J.; Carlson, H. A. Binding MOAD, a
high-quality protein-ligand database. Nucleic Acids Res. 2008, 36, D674–
D678.
(28) Hu, L.; Benson, M. L.; Smith, R. D.; Lerner, M. G.; Carlson,
H. A. Binding MOAD (Mother Of All Databases). Proteins: Struct.,
Funct., Bioinf. 2005, 60, 333–340.
(29) Wang, R.; Fang, X.; Lu, Y.; Wang, S. The PDBbind database:
collection of binding aﬃnities for protein-ligand complexes with known
three-dimensional structures. J. Med. Chem. 2004, 47, 2977–2980.
(30) Wang,R.;Fang,X.;Lu,Y.;Yang,C.-Y.; Wang,S.ThePDBbind
database: methodologies and updates. J. Med. Chem. 2005, 48,
4111–4119.
(31) Morris, G. M.; Goodsell, D. S.; Huey, R.; Olson, A. J. Dis-
tributed automated docking of ﬂexible ligands to proteins: parallel
applications of AutoDock 2.4. J. Comput.-Aided Mol. Des. 1996,
10, 293–304.
(32) Trott, O.; Olson, A. J. Software News and Update AutoDock
Vina:ImprovingtheSpeedandAccuracyofDockingwithaNewScoring
Function, Eﬃcient Optimization and Multithreading. J. Comput. Chem.
2010, 31, 455–461.
(33) Shoichet, B. K.; Bodian, D. L.; Kuntz, I. D. Molecular Docking
Using Shape Descriptors. J. Comput. Chem. 1992, 13, 380–397.
(34) Gohlke, H.; Hendlich, M.; Klebe, G. Knowledge-based scoring
function to predict protein-ligand interactions. J. Mol. Biol. 2000, 295,
337–356.
(35) Zsoldos, Z.; Reid, D.; Simon, A.; Sadjad, S. B.; Johnson, A. P.
eHiTS: a new fast, exhaustive ﬂexible ligand docking system. J. Mol.
Graph. Model. 2007, 26, 198–212.
(36) FRED; version 2.2.5; OpenEye Scientiﬁc Software, Inc.: Santa
FRED, NM 87508, 2009.
(37) Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.;
Klicic,J.J.;Mainz,D.T.;Repasky,M.P.;Knoll,E.H.;Shelley,M.;Perry,
J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: a new approach for
rapid, accurate docking and scoring. 1. Method and assessment of
docking accuracy. J. Med. Chem. 2004, 47, 1739–1749.
(38) Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.;
Taylor, R. D. Improved protein-ligand docking using GOLD. Proteins:
Struct., Funct., Bioinf. 2003, 52, 609–623.
(39) Kramer, C.; Gedeck, P. Global free energy scoring functions
based on distance-dependent atom-type pair descriptors. J.Chem. Inf.
Model. 2011, 51, 707–720.
(40) Huang, S.-Y.; Zou, X. An iterative knowledge-based scoring
function to predict protein-ligand interactions: I. Derivation of interac-
tion potentials. J. Comput. Chem. 2006, 27, 1866–1875.
(41) Stroganov, O. V.; Novikov, F. N.; Stroylov, V. S.; Kulkov, V.;
Chilov, G. G. Lead ﬁnder: an approach to improve accuracy of protein-
ligand docking, binding energy estimation, and virtual screening.
J. Chem. Inf. Model. 2008, 48, 2371–2385.
(42) Build_model; version 2.0.1 build 07.30; MolTech Ltd.:
20082011.
(43) Yin, S.; Biedermannova, L.; Vondrasek, J.; Dokholyan, N. V.
MedusaScore: an accurate force ﬁeld-based scoring function for virtual
drug screening. J. Chem. Inf. Model. 2008, 48, 1656–1662.
(44) Molecular Operating Environment (MOE); version 2010.10;
Chemical Computing Group: Montreal, C.N., 2010.
(45) Goto, J.; Kataoka, R.; Muta, H.; Hirayama, N. ASEDock-
docking based on alpha spheres and excluded volumes. J. Chem. Inf.
Model. 2008, 48, 583–590.
(46) Yang, C.-Y.; Wang, R.; Wang, S. M-score: a knowledge-based
potential scoring function accounting for protein atom mobility. J. Med.
Chem. 2006, 49, 5903–5911.
(47) Rahaman, O.; Estrada, T.; Doran, D.; Taufer, M.; Brooks, C.;
Armen, R. Evaluation of Several Two-step Scoring Functions Based on
Linear Interaction Energy, Eﬀective Ligand Size, and Empirical Pair
Potentials for Prediction of Protein-Ligand Binding Geometry and Free
Energy. J. Chem. Inf. Model. 2011, DOI: 10.1021/ci1003009.
(48) Naim,M.;Bhat,S.;Rankin,K.N.;Dennis,S.;Chowdhury,S.F.;
Siddiqi, I.; Drabik, P.; Sulea, T.; Bayly, C. I.; Jakalian, A.; Purisima, E. O.
Solvated interaction energy (SIE) for scoring protein-ligand binding
aﬃnities. 1. Exploring the parameter space. J. Chem. Inf. Model. 2007,
47, 122–133.2130 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
Journal of Chemical Information and Modeling ARTICLE
(49) Wang,R.;Lai,L.;Wang,S.Furtherdevelopmentandvalidation
of empirical scoring functions for structure-based binding aﬃnity
prediction. J. Comput. Aid. Mol. Des. 2002, 16,1 1 –26.
(50) R:ALanguageandEnvironmentforStatisticalComputing;Team,
R. D. C.; version 2.9.2; R Project for Statistical Computing: Vienna,
Austria, 2009.
(51) Bonett, D. G.; Wright, T. A. Sample Size Requirements for
Estimating Pearson, Kendall and Spearman Correlatons. Psychometrika
2000, 65,2 3 –28.
(52) JMP; version 9.0.0; SAS institute Inc.: Cary, N.C.: 2010.
(53) Davis, I. W.; Leaver-Fay, A.; Chen, V. B.; Block, J. N.; Kapral,
G. J.; Wang, X.; Murray, L. W.; Arendall, W. B., 3rd; Snoeyink, J.;
Richardson, J. S.; Richardson, D. C. MolProbity: all-atom contacts and
structure validation for proteins and nucleic acids. Nucleic Acids Res.
2007, 35, W375–W383.
(54) Vriend, G. WHAT IF: a molecular modeling and drug design
program. J. Mol. Graph. 1990, 8,5 2 –56.
(55) Cruickshank,D. W.Remarks about proteinstructure precision.
Acta Crystallogr. D 1999, 55, 583–601.
(56) Smith, R. D.; Hu, L.; Falkner, J. A.; Benson, M. L.; Nerothin,
J. P.; Carlson, H. A. Exploring protein-ligand recognition with Binding
MOAD. J. Mol. Graphics Modell. 2006, 24, 414–425.
(57) Wallin, R.; Hutson, S. M. Warfarin and the vitamin K-depen-
dentgamma-carboxylationsystem.TrendsMol.Med.2004,10,299–302.
(58) Liebeschuetz, J. W.; Jones, S. D.; Morgan, P. J.; Murray, C. W.;
Rimmer, A. D.; Roscoe, J. M.; Waszkowycz, B.; Welsh, P. M.; Wylie,
W. A.; Young, S. C.; Martin, H.; Mahler, J.; Brady, L.; Wilkinson, K.
PRO_SELECT:combiningstructure-baseddrugdesignandarray-based
chemistry for rapid lead discovery. 2. The development of a series of
highly potent and selective factor Xa inhibitors. J. Med. Chem. 2002,
45, 1221–1232.
(59) Huang, N.; Shoichet, B. K.; Irwin, J. J. Benchmarking sets for
molecular docking. J. Med. Chem. 2006, 49, 6789–6801.
(60) Murcia, M.; Ortiz, A. R. Virtual screening with ﬂexible docking
and COMBINE-based models. Application to a series of factor Xa
inhibitors. J. Med. Chem. 2004, 47, 805–820.
(61) Nazare, M.; Will, D. W.; Matter, H.; Schreuder, H.; Ritter, K.;
Urmann, M.; Essrich, M.; Bauer, A.; Wagner, M.; Czech, J.; Lorenz, M.;
Laux, V.; Wehner, V. Probing the subpockets of factor Xa reveals two
binding modes for inhibitors based on a 2-carboxyindole scaﬀold: a
study combining structure-activity relationship and X-ray crystallogra-
phy. J. Med. Chem. 2005, 48, 4511–4525.
(62) Pinto,D.J.;Orwat,M.J.;Koch,S.;Rossi,K.A.;Alexander,R.S.;
Smallwood, A.; Wong, P. C.; Rendina, A. R.; Luettgen, J. M.; Knabb,
R. M.; He, K.; Xin, B.; Wexler, R. R.; Lam, P. Y. Discovery of 1-(4-
methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tet-
rah ydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-
562247), a highly potent, selective, eﬃcacious, and orally bioavailable
inhibitor of blood coagulation factor Xa. J. Med. Chem. 2007, 50,
5339–5356.
(63) Qiao, J. X.; Chang, C. H.; Cheney, D. L.; Morin, P. E.; Wang,
G. Z.; King, S. R.; Wang, T. C.; Rendina, A. R.; Luettgen, J. M.; Knabb,
R.M.;Wexler,R.R.;Lam,P.Y.SARandX-raystructuresofenantiopure
1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives
as inhibitors of coagulation Factor Xa. Bioorg. Med. Chem. Lett. 2007,
17, 4419–4427.
(64) Qiao, J. X.; Cheng, X.; Smallheer, J. M.; Galemmo, R. A.;
Drummond, S.; Pinto, D. J.; Cheney, D. L.; He, K.; Wong, P. C.;
Luettgen, J. M.; Knabb, R. M.; Wexler, R. R.; Lam, P. Y. Pyrazole-based
factor Xa inhibitors containing N-arylpiperidinyl P4 residues. Bioorg.
Med. Chem. Lett. 2007, 17, 1432–1437.
(65) Senger, S.; Convery, M. A.; Chan, C.; Watson, N. S. Arylsulfo-
namides:astudyoftherelationshipbetweenactivityandconformational
preferences for a series of factor Xa inhibitors. Bioorg. Med. Chem. Lett.
2006, 16, 5731–5735.
(66) Watson, N. S.; Brown, D.; Campbell, M.; Chan, C.; Chaudry,
L.;Convery,M.A.;Fenwick,R.;Hamblin,J.N.;Haslam,C.;Kelly,H.A.;
King, N. P.; Kurtis, C. L.; Leach, A. R.; Manchee, G. R.; Mason, A. M.;
Mitchell,C.;Patel,C.;Patel,V.K.;Senger,S.;Shah,G.P.;Weston,H.E.;
Whitworth, C.; Young, R. J. Design and synthesis of orally active
pyrrolidin-2-one-based factor Xa inhibitors. Bioorg. Med. Chem. Lett.
2006, 16, 3784–3788.
(67) Ye, B.; Arnaiz, D. O.; Chou, Y. L.; Griedel, B. D.; Karanjawala,
R.; Lee, W.; Morrissey, M. M.; Sacchi, K. L.; Sakata, S. T.; Shaw, K. J.;
Wu, S. C.; Zhao, Z.; Adler, M.; Cheeseman, S.; Dole, W. P.; Ewing, J.;
Fitch, R.; Lentz, D.; Liang, A.; Light, D.; Morser, J.; Post, J.; Rumennik,
G.; Subramanyam, B.; Sullivan, M. E.; Vergona, R.; Walters, J.; Wang,
Y. X.; White, K. A.; Whitlow, M.; Kochanny, M. J. Thiophene-anthra-
nilamides as highly potent and orally available factor Xa inhibitors.
J. Med. Chem. 2007, 50, 2967–2980.
(68) Young, R. J.; Brown, D.; Burns-Kurtis, C. L.; Chan, C.;
Convery, M. A.; Hubbard, J. A.; Kelly, H. A.; Pateman, A. J.; Patikis,
A.; Senger, S.; Shah, G. P.; Toomey, J. R.; Watson, N. S.; Zhou, P.
Selective and dual action orally active inhibitors of thrombin and factor
Xa. Bioorg. Med. Chem. Lett. 2007, 17, 2927–2930.
(69) Young, R. J.; Campbell, M.; Borthwick, A. D.; Brown, D.;
Burns-Kurtis, C. L.; Chan, C.; Convery, M. A.; Crowe, M. C.; Dayal, S.;
Diallo, H.; Kelly, H. A.; King, N. P.; Kleanthous, S.; Mason, A. M.;
Mordaunt, J. E.; Patel, C.; Pateman, A. J.; Senger, S.; Shah, G. P.; Smith,
P. W.; Watson, N. S.; Weston, H. E.; Zhou, P. Structure- and property-
baseddesignoffactorXainhibitors:pyrrolidin-2-oneswithacyclicalanyl
amides as P4 motifs. Bioorg. Med. Chem. Lett. 2006, 16, 5953–5957.
(70) Verdonk, M. L.; Berdini, V.; Hartshorn, M. J.; Mooij, W. T.;
Murray,C.W.;Taylor,R.D.;Watson,P.Virtualscreeningusingprotein-
ligand docking: avoiding artiﬁcial enrichment. J. Chem. Inf. Comput. Sci.
2004, 44, 793–806.
(71) Jacobsson, M.; Karlen, A. Ligand bias of scoring functions in
structure-based virtual screening. J. Chem. Inf. Model. 2006, 46, 1334–
1343.
(72) Krovat, E. M.; Steindle, T.; Langer, T. Recent advances in
docking and scoring. Curr. Comput.-Aided Drug Des. 2005, 1,9 3 –102.
(73) Carlson, H. A.; Smith, R. D.; Khazanov, N. A.; Kirchhoﬀ, P. D.;
Dunbar, J. B.; Benson, M. L. Diﬀerences between high- and low-aﬃnity
complexes of enzymes and nonenzymes. J. Med. Chem. 2008, 51, 6432–
6441.
(74) Gohlke, H.; Klebe, G. Approaches to the description
and prediction of the binding aﬃnity of small-molecule ligands to
macromolecular receptors. Angew. Chem., Int. Ed. Engl. 2002, 41, 2644–
2676.
(75) Davis, A. M.; Teague, S. J. Hydrogen Bonding, Hydrophobic
Interactions, and Failure of the Rigid Receptor Hypothesis. Angew.
Chem., Int. Ed. Engl. 1999, 38, 736–749.
(76) Wildman, S. A.; Crippen, G. M. Prediction of physicochemical
parameters by atomic contributions. J. Chem. Inf. Comput. Sci. 1999,
39, 868–873.
(77) David, L.; Amara, P.; Field, M. J.; Major, F. Parametrization of
a force ﬁeld for metals complexed to biomacromolecules: applications
to Fe(II), Cu(II) and Pb(II). J. Comput.- Aided Mol. Des. 2002, 16,
635–651.
(78) Irwin, J. J.; Raushel, F. M.; Shoichet, B. K. Virtual screening
against metalloenzymesforinhibitors andsubstrates. Biochemistry 2005,
44, 12316–12328.
(79) Li, X.; Hayik, S. A.; Merz, K. M., Jr. QM/MM X-ray reﬁnement
of zinc metalloenzymes. J. Inorg. Biochem. 2010, 104, 512–522.
(80) Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.
Experimental and Compoutational Approaches to Estimate Solubility
and Permeability in Drug Discover and Development Settings. Adv.
Drug Delivery Rev. 1997, 23,3 –25.
(81) Oprea, T. I. Property distribution of drug-related chemical
databases. J. Comput.- Aided Mol. Des. 2000, 14, 251–264.
(82) Hunenberger, P. H.; Helms, V.; Narayana, N.; Taylor, S. S.;
McCammon, J. A. Determinants of ligand binding to cAMP-dependent
protein kinase. Biochemistry 1999, 38, 2358–2366.
(83) Brown, S. P.; Muchmore, S. W.; Hajduk, P. J. Healthy skepti-
cism:assessingrealisticmodelperformance.DrugDiscoveryToday2009,
14, 420–427.2131 dx.doi.org/10.1021/ci200269q |J. Chem. Inf. Model. 2011, 51, 2115–2131
Journal of Chemical Information and Modeling ARTICLE
(84) Czodrowski, P.; Sotriﬀer, C. A.; Klebe, G. Protonation changes
upon ligand binding to trypsin and thrombin: structural interpretation
based on pKa calculations and ITC experiments. J. Mol. Biol. 2007,
367, 1347–1356.
(85) Chow, M. A.; McElroy, K. E.; Corbett, K. D.; Berger, J. M.;
Kirsch,J.F.Narrowingsubstratespeciﬁcityinadirectlyevolvedenzyme:
the A293D mutant of aspartate aminotransferase. Biochemistry 2004,
43, 12780–12787.
(86) Goldberg, R. N.; Kishore, N.; Lennen, R. M. Thermodynamic
Quantities for the Ionization Reactions of Buﬀers. J. Phys. Chem. Ref.
Data 2002, 31, 231–370.
’NOTE ADDED IN PROOF
We thank Yu Zhou of the National Institute of Biological
Sciences, Beijing for informing us that the ligand in 1x8d (set 2,
no. 121) was incorrectly protonated. It is a sugar, and one of the
hydroxylgroupswasmisinterpretedtobeaketone. Asonemight
expect, it was indeed one of the BAD structures, improperly
scored across most methods. A corrected version is available for
download on the CSAR website (www.CSARdock.org, accessed
August 24, 2011).